The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity
USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...
The company has developed a multiplex panel for bacterial and yeasts infections that it plans to submit for FDA clearance in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback